Supplemental Material, Manuscript_ID_JPP-17-0183_Enterococcal_BSI_-_Supplemental_Table_1JPP-17-0183.R2 - Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible <i>Enterococcus</i> spp. Bloodstream Infections
Jesse M. Fletcher
Shawn J. Kram
Christina B. Sarubbi
Deverick J. Anderson
Bridgette L. Kram
10.25384/SAGE.9801827.v1
https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_Manuscript_ID_JPP-17-0183_Enterococcal_BSI_-_Supplemental_Table_1JPP-17-0183_R2_-_Effectiveness_of_Vancomycin_or_Beta-Lactam_Therapy_in_Ampicillin-Susceptible_i_Enterococcus_i_spp_Bloodstream_Infections/9801827
<p>Supplemental Material, Manuscript_ID_JPP-17-0183_Enterococcal_BSI_-_Supplemental_Table_1JPP-17-0183.R2 for Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible <i>Enterococcus</i> spp. Bloodstream Infections by Jesse M. Fletcher, Shawn J. Kram, Christina B. Sarubbi, Deverick J. Anderson and Bridgette L. Kram in Journal of Pharmacy Practice</p>
2019-09-11 10:06:17
bacteremia
ampicillin
infectious disease
antibiotics
endocarditis